The Hedgehog signaling pathway in cancer pathogenesis and therapy

Signaling Pathways in Cancer Pathogenesis and Therapy

Volumn , Issue , 2013, Pages 55-79

  Read, Margaret A ^a   Palombella, Vito J ^a  

^a Infinity Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929271095     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1216-8_5     Document Type: Chapter

References (105)

1. Alcedo J, Ayzenzon M, Von Ohlen T, Noll M, Hooper JE (1996) The Drosophila smoothened gene encodes a seven-pass membrane protein, a putative receptor for the hedgehog signal. Cell 86:221-232
2. Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, Hollingsworth M. A (2008) Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 14:5995-6004
3. Bailey JM, Mohr AM, Hollingsworth M. A (2009) Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 28:3513-3525
4. Bale AE, Yu KP (2001) The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 10:757-762
5. Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A (2007) Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25:2524-2533
6. Baselga J (2006) Targeting tyrosine kinases in cancer: the second wave. Science 312:1175-1178
7. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, Mitchell HF, Donis-Keller H, Helms C, Hing AV, Heng HH, Koop B, Martindale D, Rommens JM, Tsui LC, Scherer SW (1996) Identifi cation of sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 14:353-356
8. Berlin J, Bendell J, Hart LL, Firdaus I, Gore I, Hermann RC, Mackey H, Yacht B, Graham RA, Low JA, Bray GL (2010) Phase II study of GDC-0449 (HPI) with concurrent chemotherapy and bevacizumab as fi rst-line therapy for metastatic colorectal cancer. In: Proceedings of the European Society of Medical Oncology, Milan, Italy, 8-12 Oct 2010, Abstract #LBA21
9. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taipale J, Olson JM, Beachy PA (2002) Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297:1559-1561
10. Berman DM, Karhadkar SS, Maitra A, Montes de Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA (2003) Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumors. Nature 425:846-851
11. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P (2008) Role of hedgehog signaling in ovarian cancer. Clin Cancer Res 14:7659-7666
12. Campbell VT, Nadesan P, Wang Y, Whetstone H, McGovern K, Read M. A, Alman BA, Wunder JS (2011) Direct targeting of the Hedgehog pathway in primary chondrosarcoma xenografts with the smoothened inhibitor IPI-926. In: Proceedings of the American Association of Cancer Research Annual Meeting, Orlando, FL, 2-6 Apr 2011, Abstract LB380
13. Chen JK, Taipale J, Cooper MK, Beachy PA (2002) Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev 16:2743-2748
14. Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, de Sauvage F, Lefkowitz RJ (2004) Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 306:2257-2260
15. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, Beachy PA (1996) Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 383:407-413
16. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM (2006) Cancer stem cells-perspective on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 66:9339-9344
17. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A (2007) Hedgehog-Gli1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17:165-172
18. Cooper MK, Porter JA, Young KE, Beachy PA (1998) Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280:1603-1607
19. Creighton CJ, Lia X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JN, Chang JC (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106:13820-13825
20. Das S, Harris LG, Metge BJ, Liu S, Riker AI, Samant RS, Shevde LA (2009) The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin. J Biol Chem 284:22888-22897
21. Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo G-R, Veelken H, Engelhardt M, Mertelsmann R, Kelleher JF, Schultz P, Warmuth M (2007) Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 13:944-951
22. Dierks C, Beigi R, Guo G-R, Zirlik K, Stegert MR, Manley P, Trussell C, Schmitt-Graeff A, Landwerlin K, Veelken H, Warmuth M (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation. Cancer Cell 14:238-249
23. Eichberger T, Kaser A, Pixner C, Schmid C, Klingler S, Winklmayr M, Hauser-Kronberger C, Aberger F, Frischauf AM (2008) GLI2-specifi c transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells. J Biol Chem 283:12426-12437
24. Epstein E, Tang JY, Mackay-Wiggan JM, Aszterbaum M, Lindgren J, Chang K, Coppola C, Campbell A, Chanana A, Marji J, Callahan C, Yacht R, Bickers DR (2011) An investigatorinitiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients. In: Proceedings of the American Association of Cancer Research, Orlando, FL, 2-6 Apr 2011, Abstract #LB01
25. Fan L, Pepicelli CV, Dibble CC, Catbagan W, Zarycki JL, Laciak R, Gipp J, Shaw A, Lamm MLG, Munoz A, Lipinski R, Thrasher JB, Bushman W (2004) Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145:3961-3970
26. Farquharson C, Jefferies D, Seawright E, Houston B (2001) Regulation of chondrocyte terminal differentiation in the postembryonic growth plate: the role of the PtHrP-Indian Hh axis. Endocrinology 142:4131-4140
27. Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, Ouellette MM, Yu W, Maitra A (2008) Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut 57:1420-1430
28. Geng L, Cuneo KC, Cooper MK, Wang H, Sekhar K, Fu A, Hallahan DF (2007) Hedgehog signaling in the murine melanoma microenvironment. Angiogenesis 10:259-267
29. Goodrich LV, Milenkovi HKM, Scott MP (1997) Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277:1109-1113
30. Growden WB, McCann CR, Curley M, Friel AM, Mandley E, Ferguson J, Foster R, MacDougal J, Rueda BR (2009) Hedgehog pathway inhibitor cyclopamine suppresses Gli1 expression and inhibits serous ovarian cancer xenograft growth (Abstract). In: Society of Gynecologic Oncologists annual meeting, San Antonio, TX, 5-8 Feb 2009, Abstract 18
31. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851
32. Han Y-G, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ, Alvarez-Buylla AA (2009) Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med 15:1062-1065
33. He J, Sheng T, Stelter AA, Li C, Xhang X, Sinha M, Luxon BA, Xie J (2006) Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem 281:35598-35602
34. Hegde GV, Peterson KJ, Emanuel K et al (2008) Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res 6:1928-1936
35. Incardona JP, Gaffi eld W, Kapur RP, Roellink H (1998) The teratogenic ceratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125:3553-3562
36. Jackson-Fisher AJ, McMahon MJ, Lam J, Li C, Engstrom LD, Tsaparikos K, Shields DJ, Fang DD, Lira ME, Zhu Z, Robbins MD, Schwab R, Munchhof MJ, VanArsdale T (2011) PF-04449913, a small molecule inhibitor of Hedgehog signaling, is effective in inhibiting tumor growth in preclinical models. In: Proceedings of the American Association of Cancer Research Annual Meeting, Orlando, FL, 2-6 Apr 2011, Abstract #4504
37. Jiang J, Hui C (2008) Hedgehog signaling in development and cancer. Dev Cell 15:801-812
38. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428
39. Karhkadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maltra A, Isaccs JT, Berman DM, Beachy PA (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431:707-712
40. Katoh Y, Katoh M (2008) Hedgehog signaling: epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med 22:271-275
41. Kaye S, Fehrenbacher L, Holloway R, Horowitz N, Karlan B, Amit A, Slomovitz B, Chang I, Yauch RL, Reddy JC (2010) Phase 2 randomized placebo controlled study of hedgehog pathway inhibitor GDC-0449 as maintenance therapy in patients with ovarian cancer in 2nd or 3rd complete remission. In: Proceedings of the European Society of Medical Oncology, Milan, Italy, 8-12 Oct 2010, Abstract #LBA25
42. Keeler RF (1968) Teratogenic compounds of Veratrum californicum (Durand)-IV. Phytochemistry 7:303-306
43. Kovacs JJ, Whalen EJ, Liu R, Xiao K, Kim J, Chen M, Wang J, Chen W, Lefkowitz RJ (2008) b-Arrestin mediated localization of smoothened to the primary cilium. Science 320:1777-1781
44. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S, Katano M (2004) Hedgehog signaling pathway is a new target for patients with breast cancer. Cancer Res 64:6071-6074
45. Kurtova AV, Balakrishnan K, Chen R, Ding W, Schnabl S, Quiroga MP, Sivina M, Wierda WG, Estrov Z, Keating MJ, Shehata M, Jäger U, Gandhi V, Kay NE, Plunkett W, Burger JA (2009) Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 114:4441-4450
46. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri M. A, Dick JE (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648
47. Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM (2006) Snail induction is an early response to Gli1 that determines the effi ciency of epithelial transformation. Oncogene 25:609-621
48. Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S, Jones E, McGovern K, Watkins DN, Sakamoto KM, Matsui W (2010) Self-renewal of acute lymphocytic leukemia cells is limited by the hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One 5:e15262
49. Liu A, Wang B, Niswander LA (2005) Mouse intrafl agellar transport proteins regulate both the activator and repressor functions of Gli transcription factors. Development 132:3103-3111
50. Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66:6063-6071
51. Long F, Zhang XM, Karp S, Yang Y, McMahon AP (2001) Genetic manipulation of Hh signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 128:5099-5108
52. Maeda Y, Nakamura E, Nguyen M-T et al (2006) Indian Hh produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci USA 104:6382-6387
53. Mahadevan D, Von Hoff DD (2007) Tumor stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6:1186-1197
54. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133:704-715
55. McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, Welm AL, Ford HL (2009) Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest 119:2528-2531
56. Mill P, Mo R, Hu MC, Dagnino L, Rosenblum ND, Hui CC (2005) Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev Cell 9:293-303
57. Moraes RC, Zhang X, Harrington N, Fung JY, Wu MF, Hilsenbeck SG, Allred DC, Lewis MT (2007) Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation, and ductal dysplasia. Development 134:1231-1242
58. Nüsslein-Volhard C, Wieschaus E (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287:795-801
59. Ogden SK, Fei DL, Schilling NS, Ahmed YF, Hwa J, Robbins DJ (2008) G protein G a i functions immediately downstream of smoothened in hedgehog signalling. Nature 456(7224):967-970
60. Olive KP, Michael J, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben M. A, Caldwell ME, Allard D, Frese KK, DeNicola G, Feig C, Combs C, Winter SP, Ireland H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffi ths J, Tuveson DA (2009) Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457-1461
61. Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ (2003) Transcriptional profi ling of the sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 100:7331-7336
62. Pan S, Wu X, Jiqing J, Gao W, Wan Y, Cheng D, Huan D, Liu J, Englund JP, Wang Y, Peukert S, Miller-Moslin K, Yuan J, Guo R, Matsumoto M, Vattay A, Jiang Y, Tsao J, Sun F, Pferdekamper AC, Dodd S, Tuntland T, Maniara W, Kelleker JF, Yao Y, Warmuth M, Williams J, Dorsch M (2010) Discovery of NVP-LDE225, a potent and selective smoothened antagonist. Med Chem Lett 1:130-134
63. Peacock CD, Wang Q, Gesell GS, Cocoran-Schwartz IM, Jones E, Kim J, Devereux WL, Rhodes JT, Huff CA, Beachy PA, Watkins DN, Matsui W (2007) Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 104:4048-4053
64. Pérez-Caro M, Cobaleda C, González-Herrero I, Vicente-Duenãs C, Bermejo-Rodríguez C, Sánchez-Beato M, Orfao A, Pintado B, Flores T, Sánchez-Martín M, Jiménez R, Piris M. A, Sánchez-Garciá I (2009) Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J 28:8-20
65. Pink M, Proctor J, Briggs KJ, MacDougall J, Whitebread N, Tremblay MR, Grogan M, Palombella VJ, Castro AC, Adams J, Read M. A, Corcoron-Schwartz IM, Harcke T, Eberhart CG, Watkins DN, Sydor J (2008) Activity of IPI-926, a potent HH pathway inhibitor, in a novel model of medulloblastoma derived from Ptch/HIC +/-mice (Abstract). In: Proceedings of the 99th Meeting of the American Association for Cancer Research, San Diego, CA, 12-16 Apr 2008, Abstract 1588
66. Quintás-Cardama A, Kantarjian H, Cortes J (2009) Imatinib and beyond-exploring the full potential of targeted therapy for CML. Nat Rev Clin Oncol 6:535-543
67. Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C, Frischauf AM, Aberger F (2004) Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 64:7724-7731
68. Robarge KD, Brunton SA, Castanedo GM, Cui Y, Dina MS, Goldsmith R, Gould SE, Guichert O, Gunzner JL, Halladay J, Jia W, Khojasteh C, Koehler MF, Kotkow K, La H, Lalonde RL, Lau K, Lee L, Marshall D, Marsters JC Jr, Murray LJ, Qian C, Rubin LL, Salphati L, Stanley MS, Stibbard JH, Sutherlin DP, Ubhayaker S, Wang S, Wong S, Xie M (2009) GDC-0449-a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 19:5576-5581
69. Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, Muenke M (1996) Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat Genet 14:357-360
70. Rohatgi R, Milenkovic L, Scott MP (2007) Patched-1 regulates hedgehog signaling at the primary cilium. Science 317:372-376
71. Rohatgi R, Milenkovic L, Corcoran RB, Scott MP (2009) Hedgehog signal transduction by smoothened: pharmacologic evidence for a 2-step activation process. Proc Natl Acad Sci USA 106:3196-3201
72. Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, Curran T (2004) Suppression of the Shh pathway using a small molecule inhibitor eliminated medulloblastoma in Ptc1 +/-p53-/-mice. Cancer Cell 6:229-240
73. Rudin CM, Hann CL, Peacock CD, Watkins DN (2008) Novel systemic therapies for small cell lung cancer. J Natl Compr Canc Netw 6(3):1-8
74. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173-1178
75. Rudin CM, Jimeno A, Miller WH, Eigl B, Gettinger S, Chang A, Faia K, Sweeney J, Loewen G, Ross R, Weiss GJ (2011) A phase 2 study of IPI-926, a novel hedgehog pathway inhibitor, in patients with advance or metastatic solid tumors. In: Proceedings of the American Society of Clinical Oncology, Chicago, IL, 2-7 Jun 2011, Abstract #3014
76. Sarangi A, Valadez JG, Rush S, Abel TW, Thompson RC, Cooper MK (2009) Targeted inhibition of the hedgehog pathway in established malignant glioma xenografts enhances survival. Oncogene 28:3468-3476
77. Sasai K, Romer JR, Lee Y, Finkelstein D, Fuller C, McKinnon PJ, Curran T (2006) Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies. Cancer Res 66:4215-4222
78. Shaw A, Gipp J, Bushman W (2009) The sonic hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofi broblasts. Oncogene 28:4480-4490
79. Sicklick JK, Li Y-X, Jayaraman A, Kannangai R, Qi Y, Vivekanandan P, Ludlow JW, Owzar K, Chen W, Torbenson MS, Diehl AM (2006) Dysregulation of the hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 27:748-757
80. Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, Beermann F, Ruiz I, Altaba A (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA 104:5895-5900
81. Stephenson J, Richards D, Wolpin B, Becerra C, Hamm J, Messersmith W, Devens S, Cushing J, Goddard J, Schmalbach T, Fuchs CS (2011) The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients with metastatic pancreatic cancer. In: Proceedings of the American Society of Clinical Oncology, Chicago, IL, 2-7 Jun 2011, Abstract #4114
82. Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP, Beachy PA (2000) Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406:1005-1009
83. Tawbi HA, Ahnert JR, Dummer R, Thomas AL, Granvil C, Shou Y, Dey J, Mita MM, Amakye DD, Mita AC (2011) Phase I study of LDE225 in advanced solid tumors: updated analysis of safety, preliminary effi cacy, and pharmacokinetic-pharmacodynamic correlation. In: Proceedings of the American Society of Clinical Oncology, Chicago, IL, 2-7 Jun 2011, Abstract #3062
84. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw A, Hebrok M (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856
85. Tiet TD, Hopyan S, Nadesan P, Gokgoz N, Poon R, Lin AC, Yan T, Andrulis IL, Alman BA, Wunder JS (2006) Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol 168:321-330
86. Tojo H, Shibata S, Satoh Y, Kawamura M, Inazuka M, Yamakawa H, Kashiwag M, Miyamoto M, Kondo M, Oohashi T, Oguro Y, Sasaki S (2011) TAK-441, a novel investigational small molecule hedgehog pathway inhibitor for use in cancer therapy. In: Proceedings of the American Association of Cancer Research Annual Meeting, Orlando, FL, 2-6 Apr 2011, Abstract 4508
87. Travaglione V, Peacock CD, MacDougall J, McGovern J, Cushing J, Yu LC, Trudeau M, Palombella V, Adams J, Hierman J, Rhodes J, Devereux WL, Watkins DN (2008) A novel HH pathway inhibitor, IPI-926, delays tumor recurrence post-chemotherapy in a primary human SCLC xenograft model (Abstract). In: Proceedings of the 99th meeting of the American Association for Cancer Research, San Diego, CA, 12-16 Apr 2008, Abstract 4611
88. Tremblay MR, Nesler M, Weatherhead R, Castro AC (2009a) Recent patents for hedgehog pathway inhibitors for the treatment of malignancy. Expert Opin Ther Pat 19:1039-1056
89. Tremblay M, Lescarbeau A, Grogan MJ, Tan E, Lin G, Austad BC, Yu LC, Behnke ML, Nair SJ, Hagel M, White K, Conley J, Manna JD, Alvarez-Diez TM, Hoyt J, Woodward CN, Sydor JR, Pink M, MacDougall J, Campbell MJ, Cushing J, Ferguson J, Curtis MS, McGovern K, Read M. A, Palombella VJ, Adams J, Castro AC (2009b) Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). J Med Chem 52:4400-4418
90. Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, I Altaba AR (2009) Human colon cancer epithelial cells harbor active hedgehog-Gli signaling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1:1-14
91. Vestergaard J, Pedersen MW, Pedersen N, Ensinger C, Tümer Z, Tommerup N, Poulsen HS, Larsen LA (2006) Hedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitro. Lung Cancer 52:281-290
92. Villavicencio E, Khanna P, Ditzler S, Pullar B, Hansen S, Read M. A, Faia K, Hatton B, Knoblaugh S, Randolph-Habecker J, LeBlanc M, Shaw D, Friedman S, McGovern K, Olson J (2009) Activity of the Shh pathway inhibitor, IPI-926, in a mouse model of medulloblastoma. In: Proceedings of the 100th meeting of the American Association of Cancer Research, Denver, CO, 18-22 Apr 2009, Abstract #3199
93. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Mackey HM, Lum BL, Darbonne WC, Marsters JC Jr, de Sauvage FJ, Low JA (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 361:1164-1172
94. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB (2003) Hedgehog signaling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313-317
95. Welch KD, Panter KE, Lee ST, Gardner DR, Stegelmeier BL, Cook D (2009) Cyclopamineinduced synophthalmia in sheep: defi ning a critical window and toxicokinetic evaluation. J Appl Toxicol 29:414-421
96. Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Wichterle H, Kon C, Gatchalian C, Porter JA, Rubin LL, Wang FY (2003) Identifi cation of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 100:4616-4621
97. Wong SY, Seol AD, So P-L, Ermilov AN, Bichakjian CK, Epstein EH, Dlugosz AA, Reiter JR (2009) Primary cilia can both mediate and suppress hedgehog pathway-dependent tumorigenesis. Nat Med 15:1055-1061
98. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen L-C, Scott MP, Epstein EH Jr (1997) Mutations of the patched gene in several types of sporadic extracutaneous tumors. Cancer Res 57:2369-2372
99. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D et al (2008) A paracrine requirement for hedgehog signaling in cancer. Nature 455:406-410
100. Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T, Pujara K, Stinson J, Callahan CA, Tang T, Bazan JF, Kan Z, Seshagiri S, Hann CL, Gould SE, Low JA, Rudin CM, de Sauvage FJ (2009) Smoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastoma science. Science 326(5952):572-574
101. Yoon JW, Kita Y, Frank DJ, Majewski RR, Konicek BA, Nobrega M. A, Jacob H, Walterhouse D, Iannaccone P (2002) Gene expression profiling leads to identification of GLI1-binding elements in target genes and a role for multiple downstream pathways in GLI1-induced cell transformation. J Biol Chem 277:5548-5555
102. Yu M, Gipp J, Yoon JW, Iannaccone P, Walterhouse D, Bushman W (2009a) Sonic hedgehogresponsive genes in the fetal prostate. J Biol Chem 287:5620-5629
103. Yu M, Smolen GA, Zhang J, Wittner B, Schott BJ, Brachtel E, Ramaswamy S, Maheswaran S, Haber DA (2009b) A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev 23:1737-1742
104. Yuan Z, Goetz JA, Singh S, Ogden SK, Petty WJ, Black CC, Memoli VA, Dmitrovsky E, Robbins DJ (2007) Frequent requirement of hedgehog signaling in non-small cell lung carcinoma. Oncogene 26:1046-1055
105. Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, Munchhof M, VanArsdale T, Beachy PA, Reya T (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776-779